Literature DB >> 27042490

The Need for Patient Follow-up Strategies to Confirm Diabetes Mellitus in Large Scale Opportunistic Screening.

A K Savitha1, S Gopalakrishnan2, R Umadevi3, R Rama4.   

Abstract

Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both. Type 2 (non-insulin dependent) Diabetes mellitus is one of the preventable non communicable disease resulting in increased morbidity and mortality in developing countries like India. It is characterized by disorders of insulin action and/or insulin secretion. Number of people with Type 2 Diabetes is growing rapidly worldwide with economic development, ageing populations, increasing urbanisation, dietary changes, reduced physical activity and lifestyle changes. The global prevalence of diabetes is 9%, while in India it is 8.63% and in Tamil Nadu it is 10.4%. National and State programmes on Diabetes control are implemented to combat the disease burden. A detailed review of the programme modules, operational guidelines and visit to health facilities were done to understand the implementation process related to control of Diabetes mellitus. As part of these programmes, opportunistic screening is implemented for target population. Though these programmes are unique, there are few lacunae identified which are missing opportunities and time consuming. There are no strategies so far in such programmes to make the screened positive cases to undergo confirmatory tests. Since screening is only opportunistic, the screened positive cases can be subjected to undergo confirmatory tests by different methods. The specified roles and responsibilities of health staffs at various levels to ensure follow up should also be framed and followed. The objective of this article is to review the existing strategies and to suggest the need for follow up pathways to be adopted from the first contact level to the level of final confirmation for better compliance.

Entities:  

Keywords:  Metabolic disorder; NCD Programmes; Random blood sugar

Year:  2016        PMID: 27042490      PMCID: PMC4800555          DOI: 10.7860/JCDR/2016/16320.7314

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

Authors:  R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

2.  Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Authors:  Erwin P Klein Woolthuis; Wim J C de Grauw; Willem H E M van Gerwen; Henk J M van den Hoogen; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

3.  Automated telephone conversations to assess health behavior and deliver behavioral interventions.

Authors:  R H Friedman
Journal:  J Med Syst       Date:  1998-04       Impact factor: 4.460

4.  Opportunistic screening and health promotion for type 2 diabetes: an expanding public health role for the community pharmacist.

Authors:  Teerapon Dhippayom; Anjana Fuangchan; Sirirat Tunpichart; Nathorn Chaiyakunapruk
Journal:  J Public Health (Oxf)       Date:  2012-09-12       Impact factor: 2.341

5.  Patients and computers as reminders to screen for diabetes in family practice. Randomized-controlled trial.

Authors:  Tim Kenealy; Bruce Arroll; Keith J Petrie
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

6.  Opportunistic screening for diabetes in routine clinical practice.

Authors:  Mark W Ealovega; Bahman P Tabaei; Michael Brandle; Ray Burke; William H Herman
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

7.  Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.

Authors:  L A Sargeant; R K Simmons; R S Barling; R Butler; K M Williams; A T Prevost; A L Kinmonth; N J Wareham; S J Griffin
Journal:  Diabet Med       Date:  2010-09       Impact factor: 4.359

Review 8.  The forgotten risk? A systematic review of the effect of reminder systems for postpartum screening for type 2 diabetes in women with previous gestational diabetes.

Authors:  Charlotte Jeppesen; Jette Kolding Kristensen; Per Ovesen; Helle Terkildsen Maindal
Journal:  BMC Res Notes       Date:  2015-08-26

9.  Effect of mobile reminders on screening yield during opportunistic screening for type 2 diabetes mellitus in a primary health care setting: A randomized trial.

Authors:  Sathish Kumar; Hemant Deepak Shewade; Kavita Vasudevan; Kathamuthu Durairaju; V S Santhi; Bhuvaneswary Sunderamurthy; Velavane Krishnakumari; Krishna Chandra Panigrahi
Journal:  Prev Med Rep       Date:  2015-08-13
  9 in total
  1 in total

1.  Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study.

Authors:  Hongyang Jiang; Yan Zhang; Dongyan Xu; Qing Wang
Journal:  J Clin Lab Anal       Date:  2021-03-05       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.